JAK kinase modulating quinazoline derivatives and methods of use thereof

Details for Australian Patent Application No. 2010217929 (hide)

Owner Ambit Biosciences Corporation

Inventors Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo

Agent Henry Hughes Patent & Trade Mark Attorneys

Pub. Number AU-A-2010217929

PCT Pub. Number WO2010/099379

Priority 61/294,083 11.01.10 US; 61/156,447 27.02.09 US; 61/294,490 13.01.10 US

Filing date 26 February 2010

Wipo publication date 2 September 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/099379 Priority application(s): WO2010/099379

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010217934-Hyper IgE animal model with enhanced immunoglobulin heavy chain class switching to c-epsilon

2010217928-Assay for detection of human parvovirus nucleic acid